Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromes

Dominique Endres*, Evgeniy Perlov, Rick Dersch, Annette Baumgartner, Tilman Hottenrott, Benjamin Berger, Oliver Stich, Ludger Tebartz Van Elst

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background Depression is the most prevalent psychiatric disease. In addition to primary, idiopathic depression, there are multiple secondary organic forms. However, distinguishing the two can be difficult, information about cerebrospinal fluid (CSF) basic findings in patients with depressive syndromes is sparse. Therefore, we investigated CSF alterations in so far the largest sample of patients with depressive syndromes. We hypothesized that increased prevalence of CSF pleocytosis, blood-brain-barrier (BBB) dysfunction, and oligoclonal bands (OCBs) would be observed as possible markers of underlying immunological processes. Methods From January 2006 until October 2013, we performed CSF basic diagnostics in 125 patients with depressive syndromes. We also performed serum and CSF autoantibody measurements, cerebral magnetic resonance imaging (cMRI) and electroencephalography (EEG). Results Four % of the patients displayed increased CSF white blood cell counts (WBC), 46.4% had increased protein concentrations, and 19.4% had pathological albumin quotients. OCBs in the CSF were detected in 6.5%. Overall, CSF basic diagnostics were abnormal in 56%. Including instrument-based diagnostics, we found alterations in 80.8% of patients. Suicidal tendencies correlated with an increased WBC count (r=0.276, p=0.002). Limitations In this open, uncontrolled study, we investigated mainly CSF samples of depressive patients with signs of organic features. Therefore, the study cohort is not representative of idiopathic depression. Conclusions The main findings of this study are the high rates of pathological (although mainly unspecific) CSF findings. We discuss the findings regarding possible immunological mechanisms and the vascular depression hypothesis. If these findings are associated with low-level inflammation of the central nervous system, new treatment alternatives could be considered. More and better controlled research is necessary.

OriginalspracheEnglisch
ZeitschriftJournal of Affective Disorders
Jahrgang198
Seiten (von - bis)178-184
Seitenumfang7
ISSN0165-0327
DOIs
PublikationsstatusVeröffentlicht - 01.07.2016

Fördermittel

DE: None. EP: None. RD: None. AB: Consulting and lecture fees, grant and research support from Bayer Vital GmbH , Biogen Idec , Merck Serono , Novartis , Sanofi-Aventis and Teva . TH: Travel grants from Bayer Vital GmbH and Novartis. BB: Received travel grants from Bayer Vital GmbH, Ipsen Pharma GmbH and Genzyme. OS: Consulting and lecture fees, grant and research support from Bayer Vital GmbH, Biogen Idec, Genzyme , Merck Serono, Novartis, Sanofi-Aventis and Teva. LTvE: Advisory boards, lectures, or travel grants within the last three years: Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Querschnittsbereich: Gesundheitswissenschaften: Logopädie, Ergotherapie, Physiotherapie und Hebammenwissenschaft

DFG-Fachsystematik

  • 2.23-09 Biologische Psychiatrie

Fingerprint

Untersuchen Sie die Forschungsthemen von „Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromes“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren